FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070388 [Registered on: 10/07/2024] Trial Registered Prospectively
Last Modified On: 08/02/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Single Arm Study 
Public Title of Study   Is it possible to do improve post liver transplant outcomes using exercise and nutrition? 
Scientific Title of Study   To evaluate the feasibility and impact of a home based preoperative exercise and Nutrition intervention in patients with high liver frailty index on post liver transplant outcomes - a prospective interventional Trial 
Trial Acronym  PENUT Trial 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Susan Paulin 
Designation  Associate Consultant 
Affiliation  Dr. Rela Institute and medical centre 
Address  Department of Liver transplant anaesthesia and critical care, 3 rd floor, ICU office, Dr. Rela Institute and medical centre, Chennai, TN, India
Shankar Nagar, Chrompet, Chennai - 44
Kancheepuram
TAMIL NADU
60043
India 
Phone  919994519890  
Fax    
Email  Susanvercetti@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Susan Paulin 
Designation  Associate Consultant 
Affiliation  Dr. Rela Institute and medical centre 
Address  Department of Liver transplant anaesthesia and critical care, 3 rd floor, ICU office, Dr. Rela Institute and medical centre, Chennai, TN, India
Shankar Nagar, Chrompet, Chennai - 44

TAMIL NADU
60043
India 
Phone  919994519890  
Fax    
Email  Susanvercetti@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Susan Paulin 
Designation  Associate Consultant 
Affiliation  Dr. Rela Institute and medical centre 
Address  Department of Liver transplant anaesthesia and critical care, 3 rd floor, ICU office, Dr. Rela Institute and medical centre, Chennai, TN, India
Shankar Nagar, Chrompet, Chennai - 44

TAMIL NADU
600043
India 
Phone  919994519890  
Fax    
Email  Susanvercetti@gmail.com  
 
Source of Monetary or Material Support  
Dr. Rela Institute and Medical centre Department of Liver transplant anaesthesia and critical care, 3 rd floor, ICU office,RIMC, Chrompet, Chennai, TN, India 
 
Primary Sponsor  
Name  Dr. Rela Institute and Medical centre 
Address  Shankar Nagar, Chrompet, Chennai - 44 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Susan Paulin  Dr. Rela Institute and Medical Centre  Shankar Nagar, Chrompet, Chennai-44
Kancheepuram
TAMIL NADU 
919994519890

susanvercetti@gmail.com 
Dr Akila Rajakumar  Dr.Rela Institute & Medical center  Department of Liver transplant anaesthesia and critical care, 3 rd floor, ICU office, Dr. Rela Institute and medical centre, Chennai, TN, India Shankar Nagar, Chrompet, Chennai - 44 Kancheepuram TAMIL NADU 60043 India
Kancheepuram
TAMIL NADU 
04466667777

drakila.rajakumar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC-Dr. Rela Institute and medical centre  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K74||Fibrosis and cirrhosis of liver,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not Applicable  Not applicable 
Intervention  Physiotherapy exercises and diet advice  Exercises for 30 mins to be done everyday until transplant 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  All patient with chronic liver disease undergoing evaluation for liver transplantation with LFI above 4.8 at the institute would be considered for inclusion.  
 
ExclusionCriteria 
Details  1.Patient not giving consent for the study or unable to give consent
2.Age ≤ 18y
3.Patients with acute liver failure
4. Patients in ICU for 2 weeks/ICU admission in past 2 weeks
5.Re transplantation
Not likely for follow up at the study centre.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To assess survival following liver transplantation   3 months 
 
Secondary Outcome  
Outcome  TimePoints 
To assess immediate postoperative recovery outcomes
2. To assess functional performance at the end of 3 months
3. To assess the nutritional status at end of 3 months.
4. To assess the quality of life at the end of 1 year post transplant  
90 days and 1 year 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="54" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/07/2024 
Date of Study Completion (India) 01/08/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [susanvercetti@gmail.com].

  6. For how long will this data be available start date provided 15-07-2024 and end date provided 31-01-2026?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary
Modification(s)  

 Liver fraility index (LFI) assessment will be performed by the physiotherapist routinely for all liver transplant recipients as part of pre transplant evaluation. Patients with LFI above 4.0 will be enrolled in the study at the point of first contact. Dietary and exercise plan will be formulated as per the patient needs and capacity respectively. The patients will be educated regarding the need for the nutritional and exercise interventions. Fornightly compliance check will be performed telephonically or in person. Repeat assessment of LFI will be done a day prior to transplant. Post transplantation, limb and chest physiotherapy will commence from postoperative day 1 and dietician review will be taken once feeding can be started. During the time of discharge further dietary plans and exercise regimen will be provided to the patients. At the end of 3 months further review of nutritional status, functional capacity, LFI and quality of life will be done. Quality of life will be assessed repeated at the end of one year post transplantation. 

 
Close